Pharma & Biotech

The Danish pharmaceutical giant Novo Nordisk finds itself at a critical juncture, simultaneously announcing a significant medical advancement and implementing...

The biotech firm Ocugen is undergoing a significant strategic evolution, transitioning from a research-focused entity into a late-stage clinical developer...

XORTX Therapeutics is taking decisive action to address regulatory pressures. The biotechnology firm will implement a 1-for-5 reverse stock split...

Shares of Viromed Medical (VIROMED MEDICAL) continue to trade near their annual low at €5.20, despite the company receiving a...

Investors in BioNTech are assessing a new regulatory challenge that could impact the commercial prospects of its COVID-19 vaccine, Comirnaty,...

The biotechnology firm ImmunityBio finds itself caught between significant operational progress and mounting regulatory scrutiny. A recent official warning from...

Pharmaceutical giant Eli Lilly is strategically expanding its empire beyond its blockbuster weight-loss drugs. In a series of moves totaling...

The coming weeks present a critical juncture for XORTX Therapeutics as it works to maintain its position on the Nasdaq...

A Belgian court has delivered a substantial financial and legal win for BioNTech and its partner Pfizer. The ruling, issued...

A recent $100 million financing deal has provided a crucial lifeline for ImmunityBio, following a period of significant market volatility...